-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Elevance Health, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q1 2010 to Q4 2024.
- Elevance Health, Inc. Earnings Per Share, Diluted for the quarter ending December 31, 2024 was 1.88 USD/shares, a 48.9% decline year-over-year.
- Elevance Health, Inc. Earnings Per Share, Diluted for the twelve months ending December 31, 2024 was 25.7 USD/shares, a 1.82% increase year-over-year.
- Elevance Health, Inc. annual Earnings Per Share, Diluted for 2024 was 25.7 USD/shares, a 1.82% increase from 2023.
- Elevance Health, Inc. annual Earnings Per Share, Diluted for 2023 was 25.2 USD/shares, a 3.87% increase from 2022.
- Elevance Health, Inc. annual Earnings Per Share, Diluted for 2022 was 24.3 USD/shares, a 2.69% decline from 2021.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)